Physician profile
William D Spangler
NPI 1194701441
$2,836.57
in general payments reported to CMS, 2019-2025
22 companies · $507 in 2025
The $507 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $50.99 · 2021: $160 · 2022: $307 · 2023: $464 · 2024: $1,105 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,075.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $815.49 | 2021-2024 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $326.93 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Ironshore Pharmaceuticals INC. | $242.20 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $227.51 | 2021-2025 | Bexsero, Pediarix, Penmenvy |
| Pfizer INC. | $173.62 | 2019-2025 | |
| Corium, LLC | $172.42 | 2022-2024 | Azstarys |
| Cranial Technologies, INC | $121.69 | 2023-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $113.89 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $105.84 | 2024-2025 | |
| Sobi, INC | $104.36 | 2019 | |
| Sanofi Pasteur INC. | $82.54 | 2019-2025 | |
| Kaleo, INC. | $80.96 | 2019-2022 | |
| Alk-Abello, INC | $45.67 | 2025 | Neffy |
| Tris Pharma INC | $37.01 | 2020-2023 | Dyanavel Xr |
| Biomerieux INC | $31.00 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $27.79 | 2022-2025 | Flucelvax |
| Biomarin Pharmaceutical INC. | $25.88 | 2025 | Voxzogo 1.2mg |
| Takeda Pharmaceuticals U.S.A., INC. | $25.59 | 2023 | Elaprase |
| Phadia US INC. | $22.19 | 2020 | |
| Nestle Healthcare Nutrition INC. | $21.49 | 2023 | |
| Alexion Pharmaceuticals, INC. | $17.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.50 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Spangler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.